<abstract xmlns="http://www.w3.org/1999/xhtml">

Glioblastoma is a highly aggressive and complex pathology that has garnered significant interest among researchers and clinicians due to its high mortality rates. This research article provides a systematic analysis of key aspects related to glioblastoma, offering comprehensive insights into its underlying complexities. The text explores the epidemiological patterns, etiological factors, and genetic and molecular foundations underlying the development of GBM. It also examines the interplay between the immune system and the tumor, identifying specific immune markers with potential diagnostic value. The article describes the complex processes involved in tumor growth, including its interaction with surrounding tissues, the development of the tumor microenvironment, and the role of stem cells. It also provides an analysis of current treatment options and the challenges they face, particularly in relation to tumor resistance. The article concludes with a thorough examination of the changing landscape of diagnostic and therapeutic approaches. It highlights notable recent research findings and provides insight into potential advancements that could shape the future of medical interventions for glioblastoma.
</abstract>

Glioblastoma: A molecular insight into current discoveries and treatment directions

<abstract xmlns="http://www.w3.org/1999/xhtml">

Disruptions of the circadian rhythm have shown that it can lead to significant health risks. Factors such as rapid travel across different time zones, increased exposure to artificial light, and the consumption of substances like caffeine contribute to this disruption. Understanding these disruptions and its causes is crucial for improving our health and in finding solutions.
</abstract>

STN (Student Scientific Society) Anatomia-Klinika-Nauka, Division of Anatomy, Department of Human Morphology and Embryology

Division of Anatomy, Department of Human Morphology and Embryology

The negative effect on human health due to disruption of circadian rhythm in modern times

<abstract xmlns="http://www.w3.org/1999/xhtml">

Post-traumatic stress disorder (PTSD) is a mental disorder as a result of life-threatening situations which in turn affects quality of life through activities of daily living. This is attributed to a plethora of neuromolecular factors negatively affecting the functional make-up of the brain. The complex interplay of these factors include neuronal alterations and neuroplasticity, signalling molecular, astrocyte and glial cell alterations which together act as a survival mechanism in several brain regions.
</abstract>

Neuromolecular analysis of post-traumatic stress disorder – the dysregulation in neuronal and signalling pathways

<abstract xmlns="http://www.w3.org/1999/xhtml">

Endometriosis is a gynaecological disease that affects female reproductive organs by the growth of endometrium- like tissues inside and outside the pelvic cavity. This paper explored how endometriosis can lead to increased chances of infertility through a dysregulated immune system and impaired oocyte quality.
</abstract>

Understanding endometriosis: a threat to fertility

AHEAD OF PRINT

Volume 12 (2024): Issue 1 (July 2024)

Volume 11 (2023): Issue 4 (December 2023)

Volume 11 (2023): Issue 3 (December 2023)

Volume 11 (2023): Issue 2 (September 2023)

Volume 11 (2023): Issue 1 (July 2023)

Volume 10 (2022): Issue 4 (December 2022)

Volume 10 (2022): Issue 3 (September 2022)

Volume 10 (2022): Issue 2 (June 2022)

Volume 10 (2022): Issue 1 (March 2022)

Volume 9 (2021): Issue 4 (December 2021)

Volume 9 (2021): Issue 3 (September 2021)

Volume 9 (2021): Issue 2 (June 2021)

Volume 9 (2021): Issue 1 (March 2021)

Volume 8 (2020): Issue 4 (December 2020)

Volume 8 (2020): Issue 3 (December 2020)

Volume 8 (2020): Issue 2 (June 2020)

Volume 8 (2020): Issue 1 (March 2020)

Volume 7 (2019): Issue 4 (December 2019)

Volume 7 (2019): Issue 3 (October 2019)

Volume 7 (2019): Issue 2 (September 2019)

Volume 7 (2019): Issue 1 (July 2019)

Volume 6 (2018): Issue 4 (December 2018)

Volume 6 (2018): Issue 3 (December 2018)

Volume 6 (2018): Issue 2 (September 2018)

Volume 6 (2018): Issue 1 (January 2018)

Volume 5 (2017): Issue 2 (September 2017)

Volume 5 (2017): Issue 1 (March 2017)

Volume 4 (2014): Issue 2 (December 2014)

Volume 4 (2014): Issue 1 (March 2014)

Volume 3 (2011): Issue 4 (November 2011)

Volume 3 (2011): Issue 3 (October 2011)

Volume 3 (2011): Issue 2 (June 2011)

Volume 3 (2011): Issue 1 (February 2011)

Volume 2 (2010): Issue 4 (November 2010)

Volume 2 (2010): Issue 3 (April 2010)

Volume 2 (2010): Issue 2 (February 2010)

Volume 2 (2010): Issue 1 (January 2010)

Medical Journal of Cell Biology

 Information for Polish Scientists   Zgodnie z Komunikatem Ministra Nauki i Szkolnictwa Wyższego z dnia 05 stycznia 2024 r czasopismo Medical Journal of Cell Biology uzyskało 20 punktów MNiSW.  Zachęcamy Państwa do nadsyłania artykułów zgodnych z profilem tematycznym czasopisma.     The Medical Journal of Cell Biology (MJCB) is published by Sciendo owned by De Gruyter and held by the Foundation for Cell Biology and Molecular Biology. The MJCB publishes articles in open access system in English only, four times per year, predominantly in but not limited to the field of cell biology, cell and tissue engineering, as well as translational medical studies. The journal accepts both original works, which are an innovative contribution to the field of science and critical reviews relevant to the latest literature, not older than five years. Periodically, Editor in Chief, with the permission of the Managing Editor, accepts selected Clinical Case Reports.  AIMS  Medical Journal of Cell Biology (ISSN 2544-3577) is an international, double-blind peer-reviewed, open access journal. Our predominant aim is to provide an accessible but specialized platform for researches in the field of cell biology, cell and tissue engineering, as well as translational medical studies. Manuscripts related to regenerative and reconstructive medicine are especially anticipated. Each presented methodology must be precisely described to enable reproducibility of the results. However there is no limit for the length of the manuscripts, as well as for the number of included figures and tables. MJCB provides efficient review process, followed by prompt publication of latest scientific discoveries to enrich the knowledge of researchersacross the globe.   The MJCB accepts the following types of publications: research articles, review articles, clinical case reports, letters, editorials and short communications.   SCOPE  The Medical Journal of Cell Biology accepts publications covering the following thematic areas:     Biology of human, animal and plant cells  Biology of stem cells  Biology of microbes  Biotechnology and bioengineering of cells and tissues  Nanotechnology  Reconstructive and regenerative medicine  Molecular biology  Carcinogenesis and pharmacotherapy  Macro-anatomy  Clinical Anatomy     Rejection Rate   40%   Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 